As of April 2024 Dicerna Pharmaceuticals has a market cap of $2.97 Billion. This makes Dicerna Pharmaceuticals the world's 3387th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $2.97 B | -0% |
2021 | $2.97 B | 78.42% |
2020 | $1.66 B | 5.85% |
2019 | $1.57 B | 116.24% |
2018 | $0.72 B | 56.37% |
2017 | $0.46 B | 680.22% |
2016 | $59.76 M | -75.55% |
2015 | $0.24 B | -16.55% |
2014 | $0.29 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $147.22 B | 4,844.28% | ๐บ๐ธ USA |
Amgen AMGN | $144.24 B | 4,744.26% | ๐บ๐ธ USA |
Merck MRK | $318.60 B | 10,599.68% | ๐บ๐ธ USA |
Regulus Therapeutics RGLS | $0.13 B | -95.32% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $18.26 B | 513.26% | ๐บ๐ธ USA |
Arrowhead Pharmaceuticals
ARWR | $2.76 B | -7.09% | ๐บ๐ธ USA |